Category: Healthcare Technology

Healthcare TechnologyScientific Research

New Research Reveals Key Mechanism in Melanoma Treatment Resistance

Researchers have uncovered a crucial signaling pathway that allows melanoma cells to resist targeted therapies. The findings reveal how cancer cells bypass treatment through Rac1-driven mechanisms that remain resilient even when key pathways are blocked.

Breakthrough in Understanding Melanoma Resistance

Scientists have identified a critical signaling pathway that enables melanoma cells to resist targeted therapies, according to recent research published in Oncogene. The study reveals how Vav1 and Rac1 proteins collaborate to create treatment-resistant cancer cells that can bypass BRAF and MEK inhibitors, which are commonly used to treat BRAF V600-mutant melanoma.

by Darren Holt
Assistive TechnologyHealthcare Technology

Healthcare Navigation Startup Emerges With $20M To Revolutionize Patient Scheduling

A new healthcare technology startup founded by Uber mapping veterans and an emergency physician has secured $20 million to tackle what they describe as a “massive problem” in healthcare navigation. Sage Care aims to create an “air-traffic control system” for healthcare appointments, addressing systemic inefficiencies that leave patients waiting months for care while medical resources remain underutilized.

Healthcare Navigation Crisis

A new startup founded by transportation technology veterans and an emergency physician is tackling what sources indicate is a critical inefficiency in healthcare systems: the complex navigation process that leaves patients waiting months for appointments while medical resources remain underutilized. Sage Care, emerging from stealth with $20 million in funding, aims to apply ride-share dispatch principles to healthcare scheduling, according to reports from Forbes.

by Darren Holt
BiotechnologyHealthcare Technology

Circle Pharma to Present Cyclin D1 RxL Inhibition Data Showing Anti-Tumor Potential at Major Cancer Conference

Circle Pharma will present promising preclinical data on its first-in-class oral macrocyclic cyclin D1-selective inhibitors at the upcoming AACR-NCI-EORTC conference. The company’s innovative approach targets cyclin D1-driven cancers through selective disruption of the cyclin D1-Rb interaction.

Circle Pharma, a clinical-stage biopharmaceutical company focused on developing targeted macrocycle therapeutics, has announced an upcoming poster presentation highlighting the significant anti-tumor potential of cyclin D1 RxL inhibition. The presentation will occur at the prestigious AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston from October 22-26, 2025.

Conference Presentation Details and Significance

by Natalie Brooks
AI AnalyticsHealthcare Technology

AI Council Achieves Record 97% Score on US Medical Licensing Exam

Researchers have demonstrated that a council of five AI models working together can achieve unprecedented 97% accuracy on the US Medical Licensing Examination. This collaborative approach overcomes individual AI limitations and hallucinations to deliver reliable medical knowledge.

In a groundbreaking development for artificial intelligence in healthcare, a council of five AI models has achieved a record-breaking 97% score on the US Medical Licensing Examination, demonstrating that collaborative AI systems can overcome the reliability limitations of individual models. This breakthrough approach addresses the critical challenge of AI hallucinations that has previously restricted AI deployment in high-stakes medical environments.

The Challenge of AI Reliability in Medical Applications

by Natalie Brooks